{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:42:41Z","timestamp":1793378561758,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973382"],"award-info":[{"award-number":["81973382"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute lung injury (ALI) and its severe form, acute respiratory distress syndrome (ARDS), are devastating clinical disorders with high mortality, and for which more effective therapies are urgently needed. FGF1, the prototype member of the FGF family, is shown to exert protective effects against injurious stimuli in multiple disease models. Here we aimed to evaluate whether FGF1 pretreatment is protective against LPS-induced ALI and elucidate the potential underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>For drug-treated groups, C57B\/6 mice received a single i.p. injection of FGF1 (1\u00a0mg\/kg) 1\u00a0h before the LPS challenge or not. To induce the ALI model, the mice were treated by intratracheal instillation of LPS (5\u00a0mg\/kg). Then, histopathological changes in lung tissues were assessed by hematoxylin and eosin staining and transmission electron microscopy. ELISA and qPCR assays were used to detect pro-inflammatory cytokine levels in BALF and lung tissues, respectively. The total number of inflammatory cells (neutrophils and macrophages) in BALF were counted using the Wright-Giemsa method. The expressions of reactive oxygen species (ROS) and malondialdehyde (MDA) were measured using their respective kits. Western blot and immunostaining were used to evaluate the expressions of antioxidants (Nrf-2, HO-1, SOD2, GPX4, and Catalase), as well as the inflammatory and\/or apoptosis-related factors (TLR4, NF-\u03baB, and Cleaved- caspase 3).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>FGF1 pretreatment significantly ameliorated the LPS-induced histopathological changes, reduced lung wet\/dry ratios, ROS and MDA levels, total BALF protein, inflammatory cell infiltration, proinflammatory cytokine levels, and significantly increased the expression of antioxidant proteins (Nrf-2, HO-1, Catalase, and SOD2). In addition, FGF1 pretreatment significantly reduced the expression of TLR4 and cleaved- caspase 3, inhibited NF-\u03baB activation, and reduced LPS-induced cell apoptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Altogether, our results suggest that FGF1 pretreatment is protective against LPS-induced ALI through mediating anti-inflammatory and antioxidant effects, which may be attributed to the downregulation of TLR4 expression and inhibition of NF-\u03baB activation, as well as promotion of antioxidant defenses. Therefore, FGF1 administration may prove beneficial in preventative strategies for ALI\/ARDS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10020-022-00502-8","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T06:16:59Z","timestamp":1656397019000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["FGF1 alleviates LPS-induced acute lung injury via suppression of inflammation and oxidative stress"],"prefix":"10.1186","volume":"28","author":[{"given":"Qhaweni","family":"Dhlamini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4436-9593","authenticated-orcid":false,"given":"Jin-San","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"502_CR1","doi-asserted-by":"publisher","first-page":"7753","DOI":"10.4049\/jimmunol.176.12.7753","volume":"176","author":"E Abraham","year":"2006","unstructured":"Abraham E, Nick JA, Azam T, Kim SH, Mira JP, Svetkauskaite D, He Q, Zamora M, Murphy J, Park JS, et al. Peripheral blood neutrophil activation patterns are associated with pulmonary inflammatory responses to lipopolysaccharide in humans. J Immunol. 2006;176:7753\u201360.","journal-title":"J Immunol"},{"key":"502_CR2","doi-asserted-by":"crossref","unstructured":"Bhattacharya S. Reactive oxygen species and cellular defense system. In Free radicals in human health and disease. 2015;17\u201329.","DOI":"10.1007\/978-81-322-2035-0_2"},{"key":"502_CR3","doi-asserted-by":"crossref","unstructured":"Bloomer RJ. Chapter 1 Effect of exercise on oxidative stress biomarkers. 2008;1\u201350.","DOI":"10.1016\/S0065-2423(08)00401-0"},{"key":"502_CR4","doi-asserted-by":"publisher","first-page":"10689","DOI":"10.1074\/jbc.274.16.10689","volume":"274","author":"JC Chow","year":"1999","unstructured":"Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem. 1999;274:10689\u201392.","journal-title":"J Biol Chem"},{"key":"502_CR5","doi-asserted-by":"crossref","unstructured":"Ding I, Liu W, Sun J, Paoni SF, Hernady E, Fenton BM, Okunieff P.&nbsp; FGF1 and VEGF mediated angiogenesis in KHT tumor-bearing mice. In: Oxygen transport to tissue XXIV (Springer), 2003; pp.&nbsp;603\u2013609.","DOI":"10.1007\/978-1-4615-0075-9_59"},{"key":"502_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/ni.2566","volume":"14","author":"HC Do-Umehara","year":"2013","unstructured":"Do-Umehara HC, Chen C, Urich D, Zhou L, Qiu J, Jang S, Zander A, Baker MA, Eilers M, Sporn PH, et al. Suppression of inflammation and acute lung injury by Miz1 via repression of C\/EBP-delta. Nat Immunol. 2013;14:461\u20139.","journal-title":"Nat Immunol"},{"key":"502_CR7","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1359\/jbmr.1999.14.6.953","volume":"14","author":"C Dunstan","year":"1999","unstructured":"Dunstan C, Boyce R, Boyce B, Garrett I, Izbicka E, Burgess W, Mundy G. Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats. J Bone Miner Res. 1999;14:953\u20139.","journal-title":"J Bone Miner Res"},{"key":"502_CR8","doi-asserted-by":"publisher","first-page":"106219","DOI":"10.1016\/j.intimp.2020.106219","volume":"80","author":"J Gao","year":"2020","unstructured":"Gao J, Liu Q, Li J, Hu C, Zhao W, Ma W, Yao M, Xing L. Fibroblast growth factor 21 dependent TLR4\/MYD88\/NF-kappaB signaling activation is involved in lipopolysaccharide-induced acute lung injury. Int Immunopharmacol. 2020;80:106219.","journal-title":"Int Immunopharmacol"},{"key":"502_CR9","doi-asserted-by":"publisher","first-page":"C1036","DOI":"10.1152\/ajpcell.00215.2011","volume":"301","author":"LE Haddad","year":"2011","unstructured":"Haddad LE, Khzam LB, Hajjar F, Merhi Y, Sirois MG. Characterization of FGF receptor expression in human neutrophils and their contribution to chemotaxis. Am J Physiol Cell Physiol. 2011;301:C1036-45.","journal-title":"Am J Physiol Cell Physiol"},{"key":"502_CR10","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.1007\/s12035-019-1512-7","volume":"56","author":"M Ikram","year":"2019","unstructured":"Ikram M, Muhammad T, Rehman SU, Khan A, Jo MG, Ali T, Kim MO. Hesperetin confers neuroprotection by regulating Nrf2\/TLR4\/NF-kappaB signaling in an abeta mouse model. Mol Neurobiol. 2019;56:6293\u2013309.","journal-title":"Mol Neurobiol"},{"key":"502_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1089\/jamp.2009.0775","volume":"23","author":"ER Johnson","year":"2010","unstructured":"Johnson ER, Matthay MA. Acute lung injury: epidemiology, pathogenesis, and treatment. J Aerosol Med Pulmonary Drug Deliv. 2010;23:243\u201352.","journal-title":"J Aerosol Med Pulmonary Drug Deliv"},{"key":"502_CR12","doi-asserted-by":"publisher","first-page":"6467","DOI":"10.4049\/jimmunol.174.10.6467","volume":"174","author":"DY Jung","year":"2005","unstructured":"Jung DY, Lee H, Jung BY, Ock J, Lee MS, Lee WH, Suk K. TLR4, but not TLR2, signals autoregulatory apoptosis of cultured microglia: a critical role of IFN-beta as a decision maker. J Immunol. 2005;174:6467\u201376.","journal-title":"J Immunol"},{"key":"502_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","volume":"13","author":"T Kawai","year":"2007","unstructured":"Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007;13:460\u20139.","journal-title":"Trends Mol Med"},{"key":"502_CR14","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1016\/j.fct.2011.07.012","volume":"49","author":"MY Kuo","year":"2011","unstructured":"Kuo MY, Liao MF, Chen FL, Li YC, Yang ML, Lin RH, Kuan YH. Luteolin attenuates the pulmonary inflammatory response involves abilities of antioxidation and inhibition of MAPK and NFkappaB pathways in mice with endotoxin-induced acute lung injury. Food Chem Toxicol. 2011;49:2660\u20136.","journal-title":"Food Chem Toxicol"},{"key":"502_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0925-4773(99)00124-0","volume":"86","author":"D Lebeche","year":"1999","unstructured":"Lebeche D, Malpel S, Cardoso WV. Fibroblast growth factor interactions in the developing lung. Mech Dev. 1999;86:125\u201336.","journal-title":"Mech Dev"},{"key":"502_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.kint.2017.05.013","volume":"93","author":"G Liang","year":"2018","unstructured":"Liang G, Song L, Chen Z, Qian Y, Xie J, Zhao L, Lin Q, Zhu G, Tan Y, Li X, et al. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism. Kidney Int. 2018;93:95\u2013109.","journal-title":"Kidney Int"},{"key":"502_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.biomaterials.2017.09.030","volume":"149","author":"P Liu","year":"2017","unstructured":"Liu P, Zhang R, Yu W, Ye Y, Cheng Y, Han L, Dong L, Chen Y, Wei X, Yu J. FGF1 and IGF1-conditioned 3D culture system promoted the amplification and cancer stemness of lung cancer cells. Biomaterials. 2017;149:63\u201376.","journal-title":"Biomaterials"},{"key":"502_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12931-015-0242-2","volume":"16","author":"B MacKenzie","year":"2015","unstructured":"MacKenzie B, Korfei M, Henneke I, Sibinska Z, Tian X, Hezel S, Dilai S, Wasnick R, Schneider B, Wilhelm J, et al. Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis. Respir Res. 2015;16:83.","journal-title":"Respir Res"},{"key":"502_CR19","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1172\/JCI60331","volume":"122","author":"MA Matthay","year":"2012","unstructured":"Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest. 2012;122:2731\u201340.","journal-title":"J Clin Invest"},{"key":"502_CR20","doi-asserted-by":"publisher","first-page":"L379","DOI":"10.1152\/ajplung.00010.2008","volume":"295","author":"G Matute-Bello","year":"2008","unstructured":"Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2008;295:L379\u201399.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"502_CR21","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","volume":"172","author":"J Mestas","year":"2004","unstructured":"Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172:2731\u20138.","journal-title":"J Immunol"},{"key":"502_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.devcel.2009.12.010","volume":"18","author":"EE Morrisey","year":"2010","unstructured":"Morrisey EE, Hogan BL. Preparing for the first breath: genetic and cellular mechanisms in lung development. Dev Cell. 2010;18:8\u201323.","journal-title":"Dev Cell"},{"key":"502_CR23","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.4049\/jimmunol.173.6.3589","volume":"173","author":"HS Park","year":"2004","unstructured":"Park HS, Jung HY, Park EY, Kim J, Lee WJ, Bae YS. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol. 2004;173:3589\u201393.","journal-title":"J Immunol"},{"key":"502_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3389\/fcell.2020.00287","volume":"8","author":"M-Y Quan","year":"2020","unstructured":"Quan M-Y, Guo Q, Liu J, Yang R, Bai J, Wang W, Cai Y, Han R, Lv Y-Q, Ding L. An FGFR\/AKT\/SOX2 signaling axis controls pancreatic cancer stemness. Front cell Dev Biol. 2020;8:287.","journal-title":"Front cell Dev Biol"},{"key":"502_CR25","doi-asserted-by":"publisher","first-page":"7664","DOI":"10.4049\/jimmunol.180.11.7664","volume":"180","author":"D Rittirsch","year":"2008","unstructured":"Rittirsch D, Flierl MA, Day DE, Nadeau BA, McGuire SR, Hoesel LM, Ipaktchi K, Zetoune FS, Sarma JV, Leng L. Acute lung injury induced by lipopolysaccharide is independent of complement activation. J Immunol. 2008;180:7664\u201372.","journal-title":"J Immunol"},{"key":"502_CR26","first-page":"352","volume":"85","author":"A Saguil","year":"2012","unstructured":"Saguil A, Fargo MV. Acute respiratory distress syndrome: diagnosis and management. Am Family Phys. 2012;85:352\u20138.","journal-title":"Am Family Phys"},{"key":"502_CR27","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1101\/gad.13.11.1361","volume":"13","author":"M Sahni","year":"1999","unstructured":"Sahni M, Ambrosetti D-C, Mansukhani A, Gertner R, Levy D, Basilico C. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev. 1999;13:1361\u20136.","journal-title":"Genes Dev"},{"key":"502_CR28","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/10715760802244768","volume":"42","author":"M Sasaki","year":"2008","unstructured":"Sasaki M, Ikeda H, Sato Y, Nakanuma Y. Proinflammatory cytokine-induced cellular senescence of biliary epithelial cells is mediated via oxidative stress and activation of ATM pathway: a culture study. Free Radic Res. 2008;42:625\u201332.","journal-title":"Free Radic Res"},{"key":"502_CR29","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature13540","volume":"513","author":"JM Suh","year":"2014","unstructured":"Suh JM, Jonker JW, Ahmadian M, Goetz R, Lackey D, Osborn O, Huang Z, Liu W, Yoshihara E, van Dijk TH, et al. Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer. Nature. 2014;513:436\u20139.","journal-title":"Nature"},{"key":"502_CR30","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1111\/jcmm.13203","volume":"21","author":"XH Tan","year":"2017","unstructured":"Tan XH, Zheng XM, Yu LX, He J, Zhu HM, Ge XP, Ren XL, Ye FQ, Bellusci S, Xiao J, et al. Fibroblast growth factor 2 protects against renal ischaemia\/reperfusion injury by attenuating mitochondrial damage and proinflammatory signalling. J Cell Mol Med. 2017;21:2909\u201325.","journal-title":"J Cell Mol Med"},{"key":"502_CR31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0272-5231(05)70158-1","volume":"21","author":"JF Tomashefski Jr","year":"2000","unstructured":"Tomashefski JF Jr. Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med. 2000;21:435\u201366.","journal-title":"Clin Chest Med"},{"key":"502_CR32","doi-asserted-by":"publisher","first-page":"25571","DOI":"10.1074\/jbc.M501920200","volume":"280","author":"MR Vargas","year":"2005","unstructured":"Vargas MR, Pehar M, Cassina P, Martinez-Palma L, Thompson JA, Beckman JS, Barbeito L. Fibroblast growth factor-1 induces heme oxygenase-1 via nuclear factor erythroid 2-related factor 2 (Nrf2) in spinal cord astrocytes: consequences for motor neuron survival. J Biol Chem. 2005;280:25571\u20139.","journal-title":"J Biol Chem"},{"key":"502_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/jmcb\/mjx047","volume":"10","author":"K Wang","year":"2018","unstructured":"Wang K, Lai C, Li T, Wang C, Wang W, Ni B, Bai C, Zhang S, Han L, Gu H, et al. Basic fibroblast growth factor protects against influenza A virus-induced acute lung injury by recruiting neutrophils. J Mol Cell Biol. 2018;10:573\u201385.","journal-title":"J Mol Cell Biol"},{"key":"502_CR34","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41419-019-1696-9","volume":"10","author":"D Wang","year":"2019","unstructured":"Wang D, Jin M, Zhao X, Zhao T, Lin W, He Z, Fan M, Jin W, Zhou J, Jin L, et al. FGF1(DeltaHBS) ameliorates chronic kidney disease via PI3K\/AKT mediated suppression of oxidative stress and inflammation. Cell Death Dis. 2019;10:464.","journal-title":"Cell Death Dis"},{"key":"502_CR35","doi-asserted-by":"publisher","first-page":"15694","DOI":"10.1074\/jbc.M601252200","volume":"281","author":"X Zhang","year":"2006","unstructured":"Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, Ornitz DM. Receptor specificity of the fibroblast growth factor family: the complete mammalian FGF family. J Biol Chem. 2006;281:15694\u2013700.","journal-title":"J Biol Chem"},{"key":"502_CR36","doi-asserted-by":"publisher","first-page":"766590","DOI":"10.3389\/fcimb.2021.766590","volume":"11","author":"K Zhang","year":"2021","unstructured":"Zhang K, Huang Q, Deng S, Yang Y, Li J, Wang S. Mechanisms of TLR4-mediated autophagy and nitroxidative stress. Front Cell Infect Microbiol. 2021;11.","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-022-00502-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-022-00502-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-022-00502-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T06:34:23Z","timestamp":1656398063000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-022-00502-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["502"],"URL":"https:\/\/doi.org\/10.1186\/s10020-022-00502-8","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"assertion":[{"value":"6 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All of the experimental procedures were performed in compliance with the National Institutes of Health guidelines and with approval from the Animal Care and Use Committee of Wenzhou Medical University, China (Ethics number: wydw2019-0510).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval\u00a0and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.\u00a0The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}